Uniformity of captopril benefit in the SAVE study: Subgroup analysis

European Heart Journal

Volumn 15, Issue SUPPL. B, 1994, Pages 2-8

  Moye, L A ^a   Pfeffer, M A ^a   Wun, C C ^a   Davis, B R ^a   Geltman, E ^a   Hayes, D ^a   Farnham, D J ^a   Randall, O S ^a   Dinh, H ^a   Arnold, J M O ^a   Kupersmth, J ^a   Hager, D ^a   Glasser, S P ^a   Biddle, T ^a   Hawkins, C M ^a   Braunwald, E ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Angiotensin converting enzyme inhibition; Congestive heart failure; Left ventricular function; Myocardial infarction

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY RISK; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL;

EID: 0028271057     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/15.suppl_b.2     Document Type: Article

References (0)